- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02219230
Use of Passive, Adaptive, and Active Prosthetic Knees in Persons With Unilateral, Transfemoral Amputation (OPK)
December 23, 2015 updated by: Brian Hafner, University of Washington
Outcomes Associated With Use of Passive, Adaptive, and Active Prosthetic Knees in Persons With Unilateral, Transfemoral Amputation: a Randomized Crossover Trial
The goals of this study are to assess measured, observed, and self-reported outcomes achieved through the use of passive (mechanical), active(motorized) and adaptive (magnetorheological) prosthetic knee control systems in individuals with unilateral, transfemoral amputation.
Study Overview
Status
Completed
Conditions
Detailed Description
An interrupted time-series trial with pre/post baseline assessments, randomized crossover of interventions, and within-phase repeated measures is used to evaluate and compare the effectiveness of the Össur Power Knee II and the Össur Rheo Knee in individuals with unilateral, transfemoral amputation.
A rigorous and clinically-meaningful experimental protocol is applied to verify study participants receive appropriate training, experience, and assessment in each knee condition.
A suite of standardized and ad-hoc physical performance tests, patient-reported questionnaires, and monitoring technologies were carefully selected to assess important, clinically-relevant participant outcomes.
Comparative effectiveness of three prosthetic knee interventions are evaluated using direct measurement (i.e., timed tests), observed clinical ratings (i.e., subjective assessments of gait quality) and self-report instruments (i.e., health status surveys).
Analyses will focus on identifying differences between control system technologies inherent to each type of prosthetic knee (i.e., passive [mechanical], adaptive [magnetorheological], and active [power]).
Outcomes will be used to establish recommendations for which activities and patients knees are most appropriate or likely to produce a desired effect.
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98195
- University of Washington
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age 45 - 75
- body weight less than 275lbs
- unilateral amputation between the hip and knee
- amputation due to non-vascular causes
- no other major limb amputations
- amputation occurred at least 2 years prior
- stable limb volume (i.e., at least 6 months on an unmodified prosthetic socket)
- intact skin tissue without open wounds or sores for at least 2 months
- physiologically stable medical condition (i.e., non-degenerative)
- possession and regular (i.e., daily) use of a prosthesis with a prosthetic knee with non-microprocessor (i.e., mechanical or fluid) stance control
- Medicare functional classification level (MFCL or "K-level") 3
Exclusion Criteria:
- expect to receive or are expected to require a replacement prosthetic socket within 15 months
- complete reliance on an assistive device (i.e., cane or walker) for ambulation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Prosthetic knee
Subjects crossed over between interventions (three different prosthetic knees).
Knee conditions include 1) Active knee (Ossur Power Knee II); 2) Adaptive knee (Ossur Rheo); and 3) Passive knee (Various manufacturers)
|
Prosthetic knee with active control system.
Other Names:
Prosthetic knee with adaptive control system.
Other Names:
Prosthetic knee with mechanical control system.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Timed Up and Go
Time Frame: Change from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)
|
Timed performance test that measures rising from a chair, walking 3m, and returning to a seated position.
|
Change from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)
|
|
Timed Ramp Test
Time Frame: Change from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)
|
Timed performance test that involves walking up and down a 14ft ramp.
|
Change from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)
|
|
Timed Stair Test
Time Frame: Change from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)
|
Timed performance test that involves walking up and down 6 steps.
|
Change from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)
|
|
Step activity
Time Frame: Change from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)
|
Average daily step counts measured by an accelerometer-based device.
|
Change from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)
|
|
Obstacle course time
Time Frame: Change from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)
|
Time to walk a 1/2-mile outdoor walking course.
|
Change from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reported Falls
Time Frame: Change from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)
|
Self-report phone survey.
|
Change from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)
|
|
Prosthesis Evaluation Questionnaire (PEQ)
Time Frame: Change from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)
|
Self-report computerized survey (12 questions)
|
Change from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)
|
|
Activities Specific Balance Confidence Scale (ABC)
Time Frame: Change from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)
|
Self-report computerized survey (18 questions).
|
Change from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)
|
|
Patient Reported Outcomes Measurement Information System (PROMIS)
Time Frame: Change from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)
|
Self-report computerized questionnaire with 8-14 questions per domain.
Includes Physical Function, Fatigue, and General Health subdomains.
|
Change from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Brian Hafner, PhD, University of Washington
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2011
Primary Completion (Actual)
September 1, 2013
Study Completion (Actual)
September 1, 2013
Study Registration Dates
First Submitted
July 29, 2014
First Submitted That Met QC Criteria
August 14, 2014
First Posted (Estimate)
August 18, 2014
Study Record Updates
Last Update Posted (Estimate)
December 28, 2015
Last Update Submitted That Met QC Criteria
December 23, 2015
Last Verified
December 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- 40660-A
- A62089 (Other Identifier: University of Washington)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Transfemoral Amputation
-
Henry M. Jackson Foundation for the Advancement...University of Miami; Walter Reed National Military Medical Center; Uniformed... and other collaboratorsUnknownTranstibial Amputation | Transfemoral AmputationUnited States
-
Össur Iceland ehfTerminatedAmputation | Transfemoral AmputationUnited States
-
Massachusetts Institute of TechnologyRecruitingTransfemoral AmputationUnited States
-
North Carolina State UniversityUniversity of North Carolina, Chapel Hill; Arizona State UniversityRecruitingTransfemoral AmputationUnited States
-
Massachusetts Institute of TechnologyU.S. Army Medical Research and Development CommandActive, not recruiting
-
VA Office of Research and DevelopmentRecruitingTranstibial Amputation | Transfemoral AmputationUnited States
-
University of Colorado, DenverUnited States Department of DefenseActive, not recruitingAmputation | Transfemoral Amputation | OsseointegrationUnited States
-
Loma Linda UniversityÖssur Iceland ehfRecruitingTransfemoral AmputationUnited States
-
University of WashingtonCongressionally Directed Medical Research ProgramsCompletedTransfemoral AmputationUnited States
-
Georgia Institute of TechnologyCompleted
Clinical Trials on Active knee (Ossur Power Knee II)
-
Liberating Technologies, Inc.Hanger Clinic: Prosthetics & OrthoticsCompletedLower Limb Amputation Above Knee (Injury) | Amputation | Prosthesis User | Amputation; Traumatic, Leg, Lower | Limb; Absence, Congenital, Lower | Amputation; Traumatic, Leg: Thigh, Between Hip and KneeUnited States
-
Liberating Technologies, Inc.Hanger Clinic: Prosthetics & OrthoticsRecruitingLower Limb Amputation Above Knee (Injury) | Amputation | Prosthesis User | Amputation; Traumatic, Leg, Lower | Limb; Absence, Congenital, Lower | Amputation; Traumatic, Leg: Thigh, Between Hip and KneeUnited States
-
Össur Iceland ehfTerminatedAmputation | Transfemoral AmputationUnited States
-
Össur Iceland ehfUniversity of IcelandActive, not recruitingFall Prevention | Balance, Falls | Amputation of Lower LimbIceland
-
Össur Iceland ehfMedical Center Orthotics and ProstheticsCompletedAmputation | Prosthesis UserUnited States
-
Loma Linda UniversityÖssur Iceland ehfRecruitingTransfemoral AmputationUnited States
-
Georgia Institute of TechnologyCompleted
-
Össur EhfCompletedAmputation | Prosthesis UserGermany, Iceland
-
Rush University Medical CenterEnovisRecruitingKnee OsteoarthritisUnited States
-
YourResearchProject Pty LtdÖssur EhfRecruitingAmputation | Prosthesis UserAustralia